The Patent Trial and Appeal Board (PTAB), on Wednesday, May 7, designated a recent Director Review decision issued by Acting Director of the U.S. Patent and Trademark Office (USPTO), Coke Morgan Stewart, as informative. The decision clarified that a district court’s final judgment of invalidity favors denial of inter partes review (IPR) under the Fintiv framework.

Full Article Available Here